Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LivaNova PLC (LIVN)
NASDAQ:LIVN
Holding LIVN?
Track your performance easily
Earnings Data
Report Date
Feb 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.8Last Year’s EPS
$0.87Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 30, 2024
|% Change Since: -12.57%
|Next Earnings Date:Feb 19, 2025
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong revenue growth, successful product launches, and increased future guidance. However, there were challenges noted in specific segments, such as epilepsy revenue declines in Europe and higher R&D expenses. The tax rate increase also poses a potential headwind.Company Guidance
During LivaNova's Q3 2024 earnings call, the company provided updated guidance for the year, reflecting its strong performance. Key metrics included an 11% revenue growth in the quarter, marking the seventh consecutive quarter of double-digit growth, with a 12% organic revenue increase year-to-date. The company achieved geographical revenue growth of 15% in the U.S. and 9% in Europe and the Rest of the World, while by business segment, cardiopulmonary grew by 15% and epilepsy by 9%. LivaNova raised its 2024 full-year guidance to 8.5%-9.5% revenue growth on a constant currency basis and 10%-11% when excluding the ACS segment wind-down impact. The adjusted operating income margin improved from 16% to 20%, and adjusted diluted earnings per share increased to $0.90 from $0.73 in the same quarter of the previous year. Additionally, the company projected an adjusted effective tax rate of 21%-22% for 2024 and adjusted free cash flow in the range of $110 million to $130 million for the year.Revenue Growth
LivaNova achieved 11% revenue growth, marking the seventh consecutive quarter of double-digit growth. Cardiopulmonary segment revenue increased by 15% compared to Q3 2023, and epilepsy revenue increased by 9%.
Market Share Gains
The company increased its oxygenator market share from the low 30s in early 2023 to the mid-30s, contributing over 100 basis points of growth year-to-date.
Essenz Launch Success
Essenz launch contributed approximately 400 basis points of growth so far in 2024, with heart-lung machine revenue increasing over 20%.
Increased 2024 Guidance
Based on Q3 performance, LivaNova increased its 2024 full-year guidance for revenue growth to between 8.5% and 9.5% on a constant currency basis.
Strong Cash Flow
Adjusted free cash flow for the quarter was $47 million, up from $26 million in the prior year period, driven by stronger operating results and working capital improvements.
---
LIVN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LIVN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $52.97 | $51.34 | -3.08% |
| Jul 31, 2024 | $51.30 | $49.40 | -3.70% |
| May 01, 2024 | $55.75 | $62.62 | +12.32% |
| Feb 21, 2024 | $52.60 | $56.82 | +8.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does LivaNova PLC (LIVN) report earnings?
LivaNova PLC (LIVN) is schdueled to report earning on Feb 19, 2025, TBA Not Confirmed.
What is LivaNova PLC (LIVN) earnings time?
LivaNova PLC (LIVN) earnings time is at Feb 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LIVN EPS forecast?
LIVN EPS forecast for the fiscal quarter 2024 (Q4) is $0.8.
---